Beyond Biotech - the podcast from Labiotech

2:05  Labiotech news
3:32  MEET2WIN
9:38 Lund Spring Symposium
19:31 Merck

This week, we’re talking about the upcoming Lund Spring Symposium with Claes Wahlestedt, Leonard M. Miller professor and directo…

1:44  Labiotech news
3:27  Molecure

This week, to coincide with World Sarcoidosis Day, April 13, we talk about sarcoidosis with Marcin Szumowski, CEO and president of the management board of Molecure. 

…

3:13  Nectin Therapeutics
26:47 Immunome

This episode of the podcast is an in-depth look at antibody drug conjugates (ADCs). Our guests are Dr Pini Tsukerman, chief scientific officer of Nectin Therape…

2:57 Labiotech.eu news
4:17 PBD Biotech
14:52 AAHI
29:36 TB Alliance

March 24 is World Tuberculosis Day. To mark the occasion, we have conversations with Christopher Fox, senior vice president, formulati…

1:27 Labiotech.eu news
2:38 Allogenica
12:06 Helex
15:51 FreezeM
19:55 MediSieve

The Hello Tomorrow Global Summit took place in Paris last week (March 8-10), and we feature interviews with four of the par…

 1:19 Labiotech.eu news
2:32 Biomedical Research & Bio-Products
12:15 Model N
21:39 Institute of Clinical Medicine

This week our guests are Marit Inngjerdingen from the Institute of Clinical Medicine in …

1:41 Labiotech.eu news
3:41 Cellular Origins
20:17 Bio-Europe Spring

Two of the interviews on the podcast today are related to Bio-Europe Spring. There are conversations with Rosie Bernard, senior direc…

0:58 Labiotech.eu news
2:37 Replay
23:45 Azafaros
39:39 GRO Biosciences

As February 28 is Rare Disease Day, we have three guests on the podcast today all relevant to rare diseases. And they are Dan Mande…

1:25 Labiotech.eu news
3:02 GPCR Therapeutics
22:16 eClinical Solutions
31:04 Orbsen Therapeutics

This week, our guests are Katrina Rice, chief delivery officer, biometrics services at eClinical Solution…

1:10 Labiotech.eu news
2:50 Innovation Agency Lithuania
25:25 Astellas Pharma
34:37 4basebio

This week, our guests are Romualda Stragienė, director at Innovation Agency Lithuania and Andrius Sliuzas, exp…

Sometimes, there’s an interview that’s just a bit long for the regular podcast. So we’re going to start an occasional series of podcasts where we look a bit more in depth at a condition, and what’s t…

01:38 Labiotech.eu news
03:18 OncoHost
18:13 Enterome
41:04 TrakCel
55:51 Cancer Research Horizons/Turbine

Our guests are Ofer Sharon, CEO of OncoHost; Matthew Lakelin, co-founder, TrakCel; Pierre Belicha…

01:22 Labiotech.eu news
03:03 Phacilitate/Advanced Therapies Week
14:15 Orgenesis
25:18 Terumo
31:47 VIVEBiotech
38:33 University of Birmingham

Phacilitate’s Advanced Therapies Week took place last week in…

02:29 Labiotech.eu news
04:11 C2i Genomics
22:31 Advanced Therapies Congress
31:37 BioAlps
47:29 Bionter
54:06 JLL

The guests on our podcast this week are: Jessica Robinson, project director, Advanced Ther…

1:03 Labiotech.eu news
2:34 Knowledge Gate
10:59 Janssen Scientific Affairs

This week, our guests are Viktoriya Vasilenko, Knowledge Gate co-founder and CEO; and Avery Ince, vice president, medical affa…

2:18 Labiotech.eu news
3: 46 Mainz Biomed
19:14 Newron

This week, we have two guests. We have conversations with Newron Pharmaceuticals' CEO, Stefan Weber, and Mainz Biomed CEO, Guido Bächler.

Mainz Biom…

1:37 Labiotech.eu news
3:34 Cradle
19:47 Rani Therapeutics

This week, we have two guests. We have conversations with Talat Imran, CEO of Rani Therapeutics; and Stef van Grieken, CEO and co-founder of Cr…

2:19 Labiotech.eu news
4:37 CellCentric
12:21 MicrofluidX
29:12 Potter Clarkson

This week, we have three guests. We have conversations with Antoine Espinet, CEO of MicrofluidX; Will West, CEO of CellCent…

2:33 Labiotech.eu news
5:03 Humacyte
23:01 Transgene
37:21 Center for Global Development
54:32 JLL

This week, we have three interviews. One is from Bio-Europe, a chat with Transgene chief business officer…

2:40 Labiotech.eu news
4:58 SOTIO Biotech
13:43 Eversana
19:37 Carl Borrebaeck
36:42 Concarlo Therapeutics

This week, we have four interviews: Franjo Hanzl, vice president commercial development Europe at…